ARCHIVES

DCT Advisors Approve Recompetition Of Drug Discovery Groups

This article is from The Cancer Letter archive.

Vol. 21 No. 25 | June 23, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

May 27, 1994

AACR 2001 Honorary Awards Announced; Nora Janjan Is ASTRO President-Elect.

January 5, 2001

Cancer Research Institute Goes To Wall Street

January 17, 1986

RFPs Available, NIH Funding Strategies

February 18, 1994

GAO Says Multiple Year Funding Not Legal; Weicker Demands Assurance That Administration Will Comply

March 29, 1985

CAB Reluctantly Approves Use Of Contract To Support Cancer Journals

February 15, 1985